Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine for Inferior Alveolar Nerve Blocks in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars: A Randomized Clinical Trial

NCT04822415 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04822415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04822415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine for Inferior Alveolar Nerve Blocks in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars: A Randomized Clinical Trial
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2014
Completion date
December 31, 2016
Enrollment
330 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic irreversible pulpitis